Short communication

Oral Fire Without Flames: Understanding Burning Mouth Syndrome and Its Clinical Implications

Abstract

Burning Mouth Syndrome (BMS) is a chronic oral pain disorder characterized by a persistent burning sensation affecting the tongue, lips, palate, or entire oral cavity without identifiable clinical abnormalities. The condition predominantly affects middle-aged and elderly women, particularly during and after menopause. Despite its significant impact on quality of life, BMS remains underdiagnosed due to its multifactorial etiology and absence of visible oral lesions. Potential contributing factors include neuropathic dysfunction, hormonal changes, psychological disturbances, nutritional deficiencies, and systemic diseases. Patients often report accompanying symptoms such as dry mouth, altered taste perception, and oral discomfort that worsens throughout the day. Diagnosis is primarily one of exclusion, requiring comprehensive clinical evaluation and laboratory investigations to rule out secondary causes. Management involves a multidisciplinary approach incorporating pharmacological therapies, behavioral interventions, nutritional correction, and patient education. This article explores the epidemiology, pathophysiology, clinical presentation, diagnostic strategies, and current treatment options for Burning Mouth Syndrome, highlighting the importance of early recognition and individualized care.

Introduction

Burning Mouth Syndrome (BMS) is a complex chronic pain condition characterized by a burning, scalding, or tingling sensation in the oral cavity without any visible mucosal abnormalities. The syndrome can significantly impair eating, speaking, and overall well-being. Although the exact cause remains unclear, advances in neurological and clinical research suggest that BMS is closely associated with dysfunction of the peripheral and central nervous systems.

Epidemiology

BMS affects approximately 1–5% of the general population and is more commonly observed in women than men. The condition is particularly prevalent among postmenopausal women, indicating a possible hormonal influence. Most cases are diagnosed between the ages of 50 and 70 years.

Clinical Presentation

Patients with BMS commonly describe:

  • Burning or scalding sensation of the tongue (glossodynia)

  • Pain involving the lips, palate, gums, or entire mouth

  • Dry mouth sensation despite normal salivary flow

  • Altered taste perception, including metallic or bitter taste

  • Increased discomfort as the day progresses

  • Sleep generally unaffected, with symptoms often absent upon waking

The intensity of symptoms may fluctuate and persist for months or years.

Pathophysiology

The exact pathogenesis of BMS remains incompletely understood. Current evidence suggests involvement of:

Peripheral Neuropathy

Damage or dysfunction of small sensory nerve fibers within the oral mucosa may contribute to abnormal pain perception.

Central Nervous System Alterations

Changes in pain-processing pathways within the brain may amplify oral sensations and contribute to chronic pain.

Hormonal Influences

Declining estrogen levels during menopause may affect oral sensory receptors and neural function.

Psychological Factors

Stress, anxiety, and depression may exacerbate symptoms and influence pain perception, although they are not considered the sole cause.

Diagnosis

BMS is a diagnosis of exclusion. A thorough evaluation should include:

  • Detailed medical and dental history

  • Clinical oral examination

  • Complete blood count

  • Assessment of vitamin and mineral levels

  • Blood glucose testing

  • Thyroid function tests

  • Salivary flow assessment

  • Microbiological testing for oral infections

  • Allergy evaluation when indicated

The absence of visible oral lesions combined with persistent burning symptoms is a key diagnostic feature.

Management and Treatment

Because BMS has multiple contributing factors, treatment should be individualized.

Pharmacological Therapies

Commonly prescribed medications include:

  • Clonazepam

  • Gabapentin

  • Alpha-lipoic acid

  • Tricyclic antidepressants

  • Selective serotonin reuptake inhibitors (SSRIs)

Non-Pharmacological Approaches

  • Cognitive behavioral therapy (CBT)

  • Stress management techniques

  • Relaxation therapy

  • Lifestyle modification

  • Avoidance of irritant foods and beverages

Nutritional Management

Correction of vitamin and mineral deficiencies can significantly improve symptoms in secondary BMS.

Prognosis

The clinical course of BMS varies among individuals. Some patients experience spontaneous improvement, while others develop persistent symptoms requiring long-term management. Early diagnosis and comprehensive treatment can enhance symptom control and improve quality of life.

Conclusion

Burning Mouth Syndrome is a challenging chronic oral pain disorder that affects both physical comfort and psychological well-being. Although its exact cause remains elusive, growing evidence supports a multifactorial origin involving neuropathic, hormonal, systemic, and psychological factors. Accurate diagnosis requires exclusion of secondary causes, while successful management depends on a personalized and multidisciplinary approach. Increased awareness among healthcare professionals can facilitate timely recognition and improve patient outcomes.

References

  1. Barbosa, N.G.; Gonzaga, A.K.G.; Fernandes, L.L.D.S.; Da Fonseca, A.G.; Queiroz, S.I.M.L.; Lemos, T.M.A.M.; Da Silveira, É.J.D.; de Medeiros, A.M.C. Evaluation of laser therapy and alpha-lipoic acid for the treatment of burning mouth syndrome: A randomized clinical trial. Lasers Med Sci. 2018, 33, 1255–1262.
  2. De Souza, I.F.; Mármora, B.C.; Rados, P.V.; Visioli, F. Treatment modalities for burning mouth syndrome: A systematic review. Clin. Oral Investig. 2018, 22, 1893–1905.
  3. Loesche, W.J.; Lopatin, D.E.; Giordano, J.; Alcoforado, G.; Hujoel, P. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunological reagents for ability to detect anaerobic periodontal infections due to Porphyromonas gingivalis, Treponema denticola, and Bacteroides forsythus. J. Clin. Microbiol. 1992, 30, 427–433.
  4. Imamura, Y.; Shinozaki, T.; Okada-Ogawa, A.; Noma, N.; Shinoda, M.; Iwata, K.; Wada, A.; Abe, O.; Wang, K.; Svensson, P. An updated review on pathophysiology and management ofburning mouth syndrome with endocrinological, psychological and neuropathic perspectives. J. Oral Rehabil. 2019, 46, 574–587.
  5. Nomura, Y.; Okada, A.; Kakuta, E.; Gunji, T.; Kajiura, S.; Hanada, N. A new screening method for periodontitis: An alternative to the community periodontal index. BMC Oral Health 2016, 16, 64.
  6. Holtfreter, B.; Albandar, J.M.; Dietrich, T.; Dye, B.A.; Eaton, K.A.; Eke, P.I.; Papapanou, P.N.; Kocher, T. Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU/USA Periodontal Epidemiology Working Group. J. Clin. Periodontol. 2015, 42, 407–412.